🌐 PhageAtLabs® — a global interactive mapping of academic laboratories in phage research.

-

🌐 PhageAtLabs® — a global interactive mapping of academic laboratories in phage research.

Take part in the project here: https://lnkd.in/e-csNChu 

Support the project here: https://ko-fi.com/thephagetherapy

PhageAtLabs® is currently under active development by The Phage Therapy team, with the aim of launching the platform this summer.

At this stage, we are actively collecting information to ensure the platform is as complete and accurate as possible. For this reason, we kindly encourage you to share this form as widely as possible with laboratories, research groups, and colleagues working on bacteriophages that you know.

This initiative is dedicated to building an interactive global map of academic laboratories and research groups working on bacteriophages. The goal is to create a structured and continuously updated database that brings together universities, institutes, and research teams involved in phage science worldwide.

While similar initiatives exist in the broader ecosystem, PhageAtLabs® is specifically focused on academic research laboratories, providing a more detailed scientific-level mapping of phage research activity. Unlike industry-oriented mappings, this project emphasizes research groups, principal investigators, and scientific focus areas, offering a clearer view of the academic foundation of the field.

The motivation behind PhageAtLabs® comes from a simple observation: academic phage research is growing rapidly, but remains highly fragmented. Information about laboratories, projects, and expertise is scattered across institutions and publications, making it difficult to access a unified global overview.

PhageAtLabs® aims to address this by consolidating this information into a single, structured, and dynamic platform. The map will allow users to explore laboratories by location, institution, and research focus, helping to better understand the global distribution of phage science.

PhageAtLabs® is expected to be publicly available this summer, with membership features becoming active at launch to support the long-term development and maintenance of the platform.

If you would like to contribute or support the development of the project, donations are greatly appreciated and directly help sustain and improve the platform.

Comments

  1. Anonymous2 July 2026 at 17:43

    Dear PhageAtLabs Team,

    I have been following your platform with great interest and wanted to ask whether there are plans to make PhageAtLabs more interactive in the future.

    In particular, I would be interested to know whether features similar to PhageAtlas or PhageTrials are planned, such as interactive search, filtering, or mapping functions for laboratories, research groups, clinical trials, phage resources, or related data.

    If such an expansion is planned, is there already an approximate timeline for when these interactive features might become available?

    Thank you in advance for your response.

    Kind regards,

    ReplyDelete
  2. Jonas2 July 2026 at 17:44

    Dear PhageAtLabs Team,

    I have been following your platform with great interest and wanted to ask whether there are plans to make PhageAtLabs more interactive in the future.

    In particular, I would be interested to know whether features similar to PhageAtlas or PhageTrials are planned, such as interactive search, filtering, or mapping functions for laboratories, research groups, clinical trials, phage resources, or related data.

    If such an expansion is planned, is there already an approximate timeline for when these interactive features might become available?

    Thank you in advance for your response.

    Kind regards,

    ReplyDelete
    Replies
    1. The Phage Therapy3 July 2026 at 01:12

      Hello Sir,
      PhageAtLabs is currently under development. We are building the foundation and will gradually add laboratories with filters, maps, and information for each lab. The tool will likely be released in mid-August or at the latest by the end of August, depending on time and budget constraints.

      Thank you for your interest in our site.
      Happy reading!

      Delete
    2. Jonas3 July 2026 at 04:35

      Hello,

      thank you very much for your response and for the update on PhageAtLabs.

      As an early-career scientist in the field of phage research, I find your work extremely valuable and inspiring. A platform like this can make a real difference for people like me who are trying to identify laboratories, understand the phage research landscape, and build a scientific path in this field.

      For me personally, your work helps make my scientific goals more tangible and supports my dream of developing a career in phage science and phage therapy.

      I am very much looking forward to the release of PhageAtLabs and will continue following your work with great interest.

      Best regards!

      Delete
    3. The Phage Therapy3 July 2026 at 05:24

      Hello,

      Thank you so much for your incredibly kind message. It genuinely means a lot to us.

      Reading that this work can help an early-career scientist make their goals more tangible and navigate the phage research landscape is probably one of the most meaningful forms of feedback we could receive. This is exactly the kind of impact we hope PhageAtLabs can have.

      We are also still students ourselves, and we know how difficult it can sometimes be to identify laboratories, understand who is working on what, and find a path into such a fascinating but still relatively specialized field. This is one of the main reasons why we wanted to build PhageAtLabs: to make the global phage research ecosystem more visible, accessible, and easier to explore for students and early-career researchers.

      Your message is therefore especially encouraging, and it gives even more meaning to the many hours of work behind the platform.

      We sincerely wish you every success in building your career in phage science and phage therapy. It is a field with an extraordinary community and so many exciting scientific questions still waiting to be explored. We truly hope that PhageAtLabs, and more broadly the work of The Phage Therapy, can support you along the way, even in a small way.

      Thank you again for taking the time to write such a thoughtful message. We deeply appreciate it, and we hope you will enjoy discovering PhageAtLabs when it is released.

      Please do not hesitate to stay in touch, and we would be very happy to hear about your own journey and research interests in the phage field.

      With our very best wishes,

      The Phage Therapy

      Delete

Post a Comment

Most Consulted Articles

Bacteriophages Disarm Inflammation-Associated E. coli Without Erasing the Gut Microbiome in IBD

-
Image
Inflammatory bowel disease is usually described through the language of immune dysregulation, chronic inflammation and genetic susceptibility. Yet an increasingly important part of the disease may lie in a more dynamic layer of biology: not simply which microorganisms inhabit the intestine, but what particular bacterial populations are doing inside it. A new study from McMaster University pushes this idea toward a striking therapeutic possibility. Instead of broadly eliminating bacteria associated with disease, bacteriophages may be used to selectively suppress the bacterial traits that help drive inflammation. McMaster researchers, from left, Kyle Jackson, Zeinab Hosseinidoust and Elena Verdu, have found a way to disarm harmful gut bacteria using precision viruses, opening the door to more personalized treatments for inflammatory bowel disease. (Georgia Kirkos, McMaster University) The work, published in Science Translational Medicine and highlighted on the journal’s cover, emerged...
Read more

History Part 12 : Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s)

-
Image
Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s) The period following World War II marked a decisive turning point in the trajectory of phage therapy in Western medicine. Despite the promising results bacteriophages had demonstrated prior to the war as potential antibacterial agents, the decades after 1945 saw a dramatic decline in interest, funding, and scientific engagement with phage therapy in the United States and much of Western Europe. This marginalization can be attributed to a confluence of scientific, sociopolitical, and economic factors that reshaped the landscape of infectious disease treatment and research. Artistic View One of the key contributors to this decline was the overwhelming optimism surrounding the newly discovered class of antibiotics. The post-war pharmaceutical revolution brought forward a series of broad-spectrum antibiotics such as streptomycin, tetracycline, and chloramphenicol, which were viewed as miracle drugs capable o...
Read more

The Phage Therapy in the spotlight !

-
Image
Bacteriophages: Ancient Predators and the Next Frontier in Medicine In the animated documentary The Deadliest Being on Planet Earth , the Kurzgesagt team delves into the world of bacteriophages—viruses that prey exclusively on bacteria. With vibrant visuals and precise narration, the video introduces viewers to an invisible ecosystem where microscopic hunters orchestrate life-and-death dramas that shape the biosphere. These entities, though virtually unknown to the general public, may soon become central to the future of medicine. At the heart of the video lies a paradox: bacteriophages (or "phages") are among the most abundant biological entities on Earth—outnumbering all other organisms combined—yet their therapeutic potential has been largely sidelined in the antibiotic era. The video outlines the historical trajectory of phage research, spotlighting FĂ©lix d’HĂ©relle’s early 20th-century work and the rise of phage therapy, only to show how it was later eclipsed by the dis...
Read more

Groundbreaking achievement : Phagos raises €25m to end bacterial disease

-
Image
 Phagos raises €25m to end bacterial disease  The company holds the first authorization to market personalized veterinary phage-based treatments on EU soil  ● Founded in 2021, Phagos is ushering in a new era in the fight against bacterial disease with bacteriophages, a powerful alternative to antibiotics. Thanks to an unprecedented regulatory breakthrough and a discovery platform combining microbiology and AI, Phagos offers the first phage-based drugs for veterinary use, a market worth tens of billions of dollars. The company plans to expand further as phage therapy becomes accepted in human health.                              ● The funding round was co-led by CapAgro, Hoxton Ventures, CapHorn, and Demeter alongside Acurio Ventures, Citizen Capital, Entrepreneur First, Founders Capital, and Station F.  ● Objectives: deploy veterinary treatments in the field, develop the next generation of pat...
Read more